Overview
The activities of the Ferrari Laboratory are based on both independent basic research and immune monitoring studies. The research revolves around three main areas of interest: class I-mediated cytotoxic CD8+ T cell responses, antibody-dependent cellular cytotoxicity (ADCC), gene expression in NK and T cellular subsets upon infection with HIV-1. With continuous funding over the last 11 years from the NIH and Bill & Melinda Gates Foundation along with many other productive collaborations within and outside of Duke, the Ferrari Lab has expanded its focus of research to include the ontogeny of HIV-1 specific immune responses that work by eliminating HIV-1 infected cells and how these can be induced by AIDS vaccine candidates.
Current Appointments & Affiliations
Professor in Surgery
·
2021 - Present
Surgery, Surgical Sciences,
Surgery
Research Professor in Molecular Genetics and Microbiology
·
2021 - Present
Molecular Genetics and Microbiology,
Basic Science Departments
Member of the Duke Human Vaccine Institute
·
2009 - Present
Duke Human Vaccine Institute,
Institutes and Centers
Affiliate, Duke Global Health Institute
·
2009 - Present
Duke Global Health Institute,
University Institutes and Centers
Recent Publications
Computationally Selected Multivalent HIV-1 Subtype C Vaccine Protects Against Heterologous SHIV Challenge
Journal Article Vaccines · February 24, 2025 Background: The RV144 trial in Thailand is the only HIV-1 vaccine efficacy trial to date to demonstrate any efficacy. Genetic signatures suggested that antibodies targeting the variable loop 2 (V2) of the HIV-1 envelope played an important protecti ... Full text CiteRapid viral suppression using integrase inhibitors during acute HIV-1 infection.
Journal Article J Antimicrob Chemother · January 3, 2025 BACKGROUND: Antiretroviral therapy (ART) is recommended for all individuals with HIV infection, including those with acute HIV-1 infection (AHI). While recommendations are similar to those for chronic infection, efficacy data regarding treatment of acute H ... Full text Link to item CiteComputationally Selected Multivalent HIV-1 Subtype C Vaccine Protects Against Heterologous SHIV Challenge
Preprint · December 18, 2024 Full text CiteRecent Grants
External Quality Assurance Program Oversight Laboratory (EQAPOL)
ResearchInvestigator · Awarded by National Institutes of Health · 2024 - 2031HVTN Lab Center: B Cell Supplement
ResearchCo Investigator · Awarded by Fred Hutchinson Cancer Center · 2023 - 2027Synthetic DNA launched & adjuvanted Immune Focused Env immunogens for HIV
ResearchPrincipal Investigator · Awarded by Wistar Institute of Anatomy and Biology · 2022 - 2027View All Grants
Education, Training & Certifications
University of Genoa (Italy) ·
1985
M.D.